시장보고서
상품코드
1942479

서맥 치료 디바이스 시장 보고서(2026년)

Bradycardia Treatment Devices Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

서맥 치료 기기 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 89억 7,000만 달러에서 2026년에는 94억 7,000만 달러로, CAGR 5.6%로 성장이 전망되고 있습니다. 지난 수년간의 성장에는 심장 리듬 장애의 유병률 증가, 병원내 순환기 부문의 심박조율기 조기 도입, 이식형 심장 리듬 관리 장치의 보급 확대, 심혈관 진단 및 모니터링 프로그램 확대, 전기생리학 및 심장 치료 인프라 확충 등이 주요 요인으로 작용한 것으로 분석됩니다.

서맥 치료 디바이스 시장 규모는 향후 수년간 꾸준한 성장이 전망되고 있습니다. 2030년에는 115억 1,000만 달러에 달하며, CAGR은 5.0%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 MRI 대응형 및 양심실 심박조율기 수요 증가, 외부형 및 웨어러블 제세동기 도입 증가, 동기능부전증후군 및 심장 차단 치료율 향상, 고령 환자의 기기 기반 리듬 안정화 요법 보급 확대, 전문 클리닉에서 심장 리듬 치료 적용 확대 등을 들 수 있습니다. 적용 확대 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 첨단 이식형 심박조율기 기술 개발 증가, 심장 리듬 관리 요법에서 서맥 치료 장치의 사용 확대, 저침습적 심장 장치 이식 시술 선호도 증가, 여러 서맥 관련 심장 질환에 대한 장치 사용 범위 확대, 장치의 안전성, 내구성 및 치료 신뢰성 향상에 집중하고 있습니다.

향후 수년간 심혈관 질환의 유병률 증가가 서맥 치료 기기 시장의 성장을 촉진할 것으로 예측됩니다. 심혈관 질환에는 관상동맥질환, 뇌졸중, 심부전 등 심장과 혈관에 영향을 미치는 병태가 포함됩니다. 심혈관 질환의 발생률 증가는 좌식 생활, 건강에 해로운 식습관, 흡연, 고령화 등의 요인과 관련이 있습니다. 심박조율기를 포함한 서맥 치료 장치는 심장병 환자의 심장 박동 리듬을 조절하고 적절한 심박수를 보장하기 위해 사용됩니다. 예를 들어 미국 비영리단체인 미국심장협회(American Heart Association)는 2024년 1월 발표에서 심혈관 질환으로 인한 연령 조정 사망률이 2024년 10만 명당 233.3명으로 2023년 10만 명당 224.4명에서 4.0% 증가할 것으로 예상했습니다. 증가했습니다. 따라서 심혈관 질환의 유병률 증가가 서맥 치료 기기 시장 확대를 주도하고 있습니다.

서맥 치료 기기 시장의 주요 기업은 환자의 치료 결과를 개선하고 시술로 인한 합병증을 최소화하기 위해 리드리스 스페이스메이커와 같은 첨단 솔루션 개발에 주력하고 있습니다. 리드리스 페이스메이커는 리드를 사용하지 않고 심장에 직접 삽입하는 소형의 독립형 장치로, 심장 리듬을 관리하기 위한 최소 침습적 대안이 될 수 있습니다. 예를 들어 미국에 본사를 둔 의료기기 제조업체인 애보트 래버러토리스(Abbott Laboratories)는 2023년 7월 AVEIR 듀얼 챔버(DR) 무균 공간 제조 시스템에 대해 미국 식품의약국(FDA)의 승인을 획득했습니다. 이 시스템은 두 개의 리드리스 페이스메이커 간에 동기화 또는 조정된 심장 페이싱을 제공하며, 부정맥 및 서맥 환자의 특정 임상적 요구에 맞게 조정됩니다.

자주 묻는 질문

  • 서맥 치료 기기 시장 규모는 어떻게 변화하고 있나요?
  • 서맥 치료 기기 시장의 성장 요인은 무엇인가요?
  • 서맥 치료 기기 시장에서 주목할 만한 기술 발전은 무엇인가요?
  • 서맥 치료 기기 시장의 주요 기업은 어디인가요?
  • 심혈관 질환의 유병률 증가가 서맥 치료 기기 시장에 미치는 영향은 무엇인가요?

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA 26.03.09

Bradycardia treatment devices are specialized tools used in medical settings to manage slow heart rates, ensuring the heart maintains a healthy rhythm and adequate blood flow throughout the body. These devices play a critical role in addressing cardiac conditions and supporting cardiovascular health.

The main types of bradycardia treatment devices include pacemakers and defibrillators. Pacemakers are medical devices that regulate the heartbeat by delivering electrical impulses to the heart. They are commonly used to treat conditions such as sinus bradycardia, sinus pause, sick sinus syndrome, tachy-brady syndrome, and heart block. These devices are typically utilized by hospitals, specialty clinics, and other healthcare facilities.

Tariffs are influencing the bradycardia treatment devices market by increasing the procurement and manufacturing costs of pacemakers, implantable defibrillators, electronic circuit components, batteries, and biocompatible casings sourced through cross-border supply chains. The impact is more pronounced across implantable pacemaker systems, biventricular devices, and defibrillator units manufactured in North America, Europe, and Asia-Pacific regions where component imports and precision assembly are cost sensitive. Hospitals and specialty cardiac clinics are experiencing extended purchasing cycles and higher capital equipment pricing as tariff-related expenses flow through distributors and suppliers. At the same time, tariffs are accelerating localization of component manufacturing, regional device assembly hubs, and strategic sourcing initiatives, which may strengthen long-term supply resilience and technological self-reliance.

The bradycardia treatment devices market research report is one of a series of new reports from The Business Research Company that provides bradycardia treatment devices market statistics, including bradycardia treatment devices industry global market size, regional shares, competitors with a bradycardia treatment devices market share, detailed bradycardia treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the bradycardia treatment devices industry. This bradycardia treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bradycardia treatment devices market size has grown strongly in recent years. It will grow from $8.97 billion in 2025 to $9.47 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rising prevalence of cardiac rhythm disorders, early adoption of pacemakers in hospital-based cardiology units, increasing availability of implantable cardiac rhythm devices, growth in cardiovascular diagnostic and monitoring programs, expansion of electrophysiology and cardiac care infrastructure.

The bradycardia treatment devices market size is expected to see steady growth in the next few years. It will grow to $11.51 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to growing demand for mri-conditional and biventricular pacemakers, rising uptake of external and wearable defibrillators, increasing treatment rates for sick sinus syndrome and heart block, higher adoption of device-based rhythm stabilization in aging patients, expanding use of cardiac rhythm therapy in specialty clinics. Major trends in the forecast period include increasing development of advanced implantable pacemaker technologies, growing use of bradycardia devices in cardiac rhythm management therapies, rising preference for minimally invasive cardiac device implantation procedures, expansion of device usage across multiple bradycardia-related cardiac conditions, focus on enhancing device safety, longevity, and treatment reliability.

The increasing prevalence of cardiovascular disease is anticipated to drive the growth of the bradycardia treatment devices market in the coming years. Cardiovascular disease includes conditions that affect the heart and blood vessels, such as coronary artery disease, stroke, and heart failure. The rising occurrence of cardiovascular disease is linked to factors including sedentary lifestyles, unhealthy diets, smoking, and aging populations. Bradycardia treatment devices, including pacemakers, are used to control heart rhythm and ensure an adequate heart rate in patients with cardiac conditions. For example, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, representing a 4.0% increase from 224.4 per 100,000 in 2023. Therefore, the growing prevalence of cardiovascular disease is driving the expansion of the bradycardia treatment devices market.

Leading companies in the bradycardia treatment devices market are focused on advancing solutions, including leadless pacemakers, to enhance patient outcomes and minimize procedural complications. Leadless pacemakers are small, self-contained devices implanted directly into the heart without the use of leads, offering a minimally invasive option for managing heart rhythm. For instance, Abbott Laboratories, a US-based medical device manufacturer, received US FDA approval in July 2023 for the AVEIR dual chamber (DR) leadless pacemaker system. This system provides synchronized or coordinated cardiac pacing between two leadless pacemakers, tailored to the specific clinical needs of patients with abnormal or slow heart rhythms.

In January 2024, Integer Holdings Corporation, a US-based provider of contract manufacturing services for medical devices, acquired Pulse Technologies, Inc. for approximately US$140 million. Through this acquisition, Integer aimed to expand its end-to-end manufacturing capabilities in high-growth segments such as leadless pacemakers, strengthening its ability to support manufacturers of bradycardia and cardiac rhythm management (CRM) devices. Pulse Technologies, Inc. is a US-based engineering and manufacturing company specializing in micro-machined components for medical device applications, including structural heart, electrophysiology, and leadless pacing technologies.

Major companies operating in the bradycardia treatment devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co KG, MicroPort Scientific Corporation, LivaNova PLC, Osypka Medical GmbH, Lepu Medical Technology Co Ltd, Pacetronix Ltd, Shree Pacetronix Ltd, Medico SpA, Zoll Medical Corporation, EBR Systems Inc, Impulse Dynamics NV, Cardioelectronica Company, IMZ Medical Devices, Oscor Inc, CCC Medical Devices, Atacor Medical, Koninklijke Philips NV

North America was the largest region in the bradycardia treatment devices market in 2025. The regions covered in the bradycardia treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bradycardia treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The bradycardia treatment devices market consists of sales of implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and leadless pacemakers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bradycardia Treatment Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses bradycardia treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bradycardia treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bradycardia treatment devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Devices: Pacemakers; Defibrillator
  • 2) By Treatment Type: Sinus Bradycardia; Sinus Pause; Sick Sinus Syndrome; Tachy-Brady Syndrome; Heart Block
  • 3) By End User: Hospitals; Specialty Clinics; Other End Users
  • Subsegments:
  • 1) By Pacemakers: Single Chamber Pacemakers; Dual Chamber Pacemakers; Biventricular Pacemakers; MRI-Conditional Pacemakers; External Pacemakers
  • 2) By Defibrillator: Implantable Cardioverter Defibrillators (ICDS); External Defibrillators; Automated External Defibrillators (AEDS); Manual External Defibrillators; Wearable Defibrillators
  • Companies Mentioned: Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Biotronik SE & Co KG; MicroPort Scientific Corporation; LivaNova PLC; Osypka Medical GmbH; Lepu Medical Technology Co Ltd; Pacetronix Ltd; Shree Pacetronix Ltd; Medico SpA; Zoll Medical Corporation; EBR Systems Inc; Impulse Dynamics NV; Cardioelectronica Company; IMZ Medical Devices; Oscor Inc; CCC Medical Devices; Atacor Medical; Koninklijke Philips NV
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Bradycardia Treatment Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Bradycardia Treatment Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Bradycardia Treatment Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Bradycardia Treatment Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Development Of Advanced Implantable Pacemaker Technologies
    • 4.2.2 Growing Use Of Bradycardia Devices In Cardiac Rhythm Management Therapies
    • 4.2.3 Rising Preference For Minimally Invasive Cardiac Device Implantation Procedures
    • 4.2.4 Expansion Of Device Usage Across Multiple Bradycardia-Related Cardiac Conditions
    • 4.2.5 Focus On Enhancing Device Safety, Longevity, And Treatment Reliability

5. Bradycardia Treatment Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Specialty Cardiology Clinics
  • 5.3 Cardiac Care Centers
  • 5.4 Ambulatory Surgical Centers
  • 5.5 Other End Users

6. Bradycardia Treatment Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Bradycardia Treatment Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Bradycardia Treatment Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Bradycardia Treatment Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Bradycardia Treatment Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Bradycardia Treatment Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Bradycardia Treatment Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Bradycardia Treatment Devices Market Segmentation

  • 9.1. Global Bradycardia Treatment Devices Market, Segmentation By Devices, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pacemakers, Defibrillator
  • 9.2. Global Bradycardia Treatment Devices Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sinus Bradycardia, Sinus Pause, Sick Sinus Syndrome, Tachy-Brady Syndrome, Heart Block
  • 9.3. Global Bradycardia Treatment Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Specialty Clinics, Other End Users
  • 9.4. Global Bradycardia Treatment Devices Market, Sub-Segmentation Of Pacemakers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single Chamber Pacemakers, Dual Chamber Pacemakers, Biventricular Pacemakers, MRI-Conditional Pacemakers, External Pacemakers
  • 9.5. Global Bradycardia Treatment Devices Market, Sub-Segmentation Of Defibrillator, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Cardioverter Defibrillators (ICDS), External Defibrillators, Automated External Defibrillators (AEDS), Manual External Defibrillators, Wearable Defibrillators

10. Bradycardia Treatment Devices Market Regional And Country Analysis

  • 10.1. Global Bradycardia Treatment Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Bradycardia Treatment Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Bradycardia Treatment Devices Market

  • 11.1. Asia-Pacific Bradycardia Treatment Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Bradycardia Treatment Devices Market

  • 12.1. China Bradycardia Treatment Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Bradycardia Treatment Devices Market

  • 13.1. India Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Bradycardia Treatment Devices Market

  • 14.1. Japan Bradycardia Treatment Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Bradycardia Treatment Devices Market

  • 15.1. Australia Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Bradycardia Treatment Devices Market

  • 16.1. Indonesia Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Bradycardia Treatment Devices Market

  • 17.1. South Korea Bradycardia Treatment Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Bradycardia Treatment Devices Market

  • 18.1. Taiwan Bradycardia Treatment Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Bradycardia Treatment Devices Market

  • 19.1. South East Asia Bradycardia Treatment Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Bradycardia Treatment Devices Market

  • 20.1. Western Europe Bradycardia Treatment Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Bradycardia Treatment Devices Market

  • 21.1. UK Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Bradycardia Treatment Devices Market

  • 22.1. Germany Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Bradycardia Treatment Devices Market

  • 23.1. France Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Bradycardia Treatment Devices Market

  • 24.1. Italy Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Bradycardia Treatment Devices Market

  • 25.1. Spain Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Bradycardia Treatment Devices Market

  • 26.1. Eastern Europe Bradycardia Treatment Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Bradycardia Treatment Devices Market

  • 27.1. Russia Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Bradycardia Treatment Devices Market

  • 28.1. North America Bradycardia Treatment Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Bradycardia Treatment Devices Market

  • 29.1. USA Bradycardia Treatment Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Bradycardia Treatment Devices Market

  • 30.1. Canada Bradycardia Treatment Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Bradycardia Treatment Devices Market

  • 31.1. South America Bradycardia Treatment Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Bradycardia Treatment Devices Market

  • 32.1. Brazil Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Bradycardia Treatment Devices Market

  • 33.1. Middle East Bradycardia Treatment Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Bradycardia Treatment Devices Market

  • 34.1. Africa Bradycardia Treatment Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Bradycardia Treatment Devices Market, Segmentation By Devices, Segmentation By Treatment Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Bradycardia Treatment Devices Market Regulatory and Investment Landscape

36. Bradycardia Treatment Devices Market Competitive Landscape And Company Profiles

  • 36.1. Bradycardia Treatment Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Bradycardia Treatment Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Bradycardia Treatment Devices Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Biotronik SE & Co KG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. MicroPort Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Bradycardia Treatment Devices Market Other Major And Innovative Companies

  • LivaNova PLC, Osypka Medical GmbH, Lepu Medical Technology Co Ltd, Pacetronix Ltd, Shree Pacetronix Ltd, Medico SpA, Zoll Medical Corporation, EBR Systems Inc, Impulse Dynamics NV, Cardioelectronica Company, IMZ Medical Devices, Oscor Inc, CCC Medical Devices, Atacor Medical, Koninklijke Philips NV

38. Global Bradycardia Treatment Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Bradycardia Treatment Devices Market

40. Bradycardia Treatment Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Bradycardia Treatment Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Bradycardia Treatment Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Bradycardia Treatment Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제